Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck's Vioxx Pain Control Is Superior To Endo's Percocet, Reps Tell Doctors

Executive Summary

Merck's attempts to boost the performance of Vioxx include sales rep distribution of data supporting the COX-2 inhibitor's superiority to Endo's Percocet, Senior Director-Investor Relations Laura Jordan told analysts during an Oct. 18 earnings call.
Advertisement

Related Content

Merck COX-2 Cardiovascular Safety Studies Will Enroll 30,000 Subjects
Merck Re-Sets Expectations For 2002: Zocor, Prilosec Are Possible Upsides
Merck Re-Sets Expectations For 2002: Zocor, Prilosec Are Possible Upsides
Merck COX-2 Cardiovascular Safety Studies Will Enroll 30,000 Subjects
Vioxx Hospital Discounts Offered; Celebrex Cleared For Acute Pain
Vioxx Hospital Discounts Offered; Celebrex Cleared For Acute Pain
COX-2 Safety Concerns Are Affecting Celebrex, Pharmacia Says
COX-2 Safety Concerns Are Affecting Celebrex, Pharmacia Says
Merck Vioxx Warning Letter Could Be Incentive For Large Cardio Safety Study
Advertisement
UsernamePublicRestriction

Register

PS038709

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel